MSB 3.21% $1.13 mesoblast limited

Ann: Update on Novartis Agreement, page-771

  1. 163 Posts.
    lightbulb Created with Sketch. 15
    and here’s why Novartis pivoted to an earlier treatment therapy
    It’s a much larger market
    The technology has been around for a while

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.